Northern Exposure PR

We are the leading public relations company serving the life science, pharmaceutical and technology industries.

Northern Exposure is the leading public relations company serving the life science, pharmaceutical and technology industries.

Twenty years experience maximising clients’ media exposure and advising on subjects from press handling, marketing strategy and reputation management

Northern Exposure Public Relations  is uniquely skilled in assisting clients in all public relations requirements

Meet Our Team


Richard Kerns

Richard Kerns

Managing Director

Richard has twenty five years’ experience working with life science companies and organisations around the globe, both independently and within larger agencies.

Edward Dutton

Edward Dutton

Vice President

Ed has over fifteen years experience of working within the pharmaceutical industry, both as a laboratory chemist and in sales and marketing roles within contract research organisations, contract manufacturers and technology based companies.

Sarah Houlton

Sarah Houlton

Technical Consultant in Residence

Sarah has a degree and PhD in chemistry from Imperial College London, and worked as a drug discovery chemist in the pharmaceutical industry. As a science journalist, she has been writing about the pharmaceutical, biotech and chemical industries for more than twenty years.

Our Services

NEPR can assist clients in numerous manners, either on a retained agency basis or through project work around events. Activities include:

Planning & research, web content creation, media relations, technical articles, thought leadership articles, trade show and event management and support, social media, product launches, crisis management & more. 

Contact us today to find out how we can assist you

Our Clients

Client News

13/09/2016 Catalent to Acquire Pharmatek, Adding Expanded Drug Development Services and Spray Drying Technology

26/09/2016 Cambrex to Acquire PharmaCore Inc., to Expand Clinical Stage API Capabilities

03/10/2016 SGS Announces Investment in New cGMP Berlin, Germany Facility

03/10/2016 Cambrex Opens New Pilot Plant at its Milan, Italy Site

04/10/2016 Catalent Biologics and Triphase Accelerator Corporation Announce License Agreement to Advance SMARTag ADC to Clinic

05/10/2016 Catalent Wins Prestigious CPhI Award for OptiForm Solution Suite Platform at CPhI Worldwide

13/10/2016 Catalent Biologics Announces Agreement with Moderna Therapeutics

17/10/2016 Cambrex Wins API Development Award at CPhI Worldwide

18/10/2016 Catalent to Provide Fill and Finish Services for Commercial Supply of Samsung Bioepis’ Biosimilar Therapy

20/10/2016 Industry Expert Kunal Jaiswal to Head Strategic Development for Catalent’s Clinical Supply Services Business

24/10/2016 Catalent Celebrates Ground Breaking for Expanded Biologics Facility

02/11/2016 SGS Life Sciences Strengthens Medical Team by Appointing Dr. Katrien Lemmens as Medical Director for Early Phase Clinical Trials

28/11/2016 Catalent Acquires Accucaps to Expand Softgel Development and Manufacturing Capabilities and Capacity

06/12/2016 Drug Formulation and Delivery Expert Dr. Joseph Reo Appointed as Catalent’s Director of Global Scientific Affairs

08/12/2016 Catalent Becomes First CDMO to Join Pharmaceutical Supply Chain Initiative: Helps SHape Better Supply China to Pharmaceutical and Healthcare Industries

15/12/2016 Catalent Biologics Collaborates with PATH Malaria Vaccine Initiative to Create Antibodies for Malaria Vaccine Research and Development

04/01/2017 Cambrex Appoints Tom Vakadeth as Executive Vice President and Chief Financial Officer

09/01/2017 Catalent to Develop Softgel Capsules for JOT’s Leading Orphan Disease Candidates

10/01/2017 SGS Clinical Research to Optimize the Fight Against the Influenza Pandemia with Novel Virus Agent for Clinical Trials

25/01/2017 SGS Increases Extractables and Leachables Identification Capabilities at its Fairfield, New Jersey Laboratory

15/02/2017 SGS Expands Elemental Impurity Testing Services at its Laboratory in Villeneuve-la-Garenne, France

16/02/2017 Catalent Completes Accucaps Acquisition to Expand Softgel Development and Manufacturing Capabilities and Capacity

23/02/2017 SGS Exprimo Launches Simulo Platform to Provide Modeling and Simulation Solutions for Clinical Trial Design and Optimization

09/03/2017 SGS to Establish Phase I Patient Clinical Pharmacology Unit at Medical Center of Defense in Budapest, Hungary

Upcoming Events

NEPR will be attending the following events:


March 20-23, 2017

New York City, USA


March 21-23, 2017

Javits Center, New York City, USA

CPhI North America

May 16-18, 2017

Pennsylvania Convention Center, USA

Pleased to be sponsoring @Rhodrilloyd93 for the coming season. Good luck to you and the whole @swintonlion team
about 4 months ago | @NrthnExposurePR